These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 11679939)

  • 1. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
    Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
    Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
    Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
    Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.
    Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H
    Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
    Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
    Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
    Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations.
    Welborn J; Jenks H; Taplett J; Walling P
    Cancer Genet Cytogenet; 2004 Nov; 155(1):33-41. PubMed ID: 15527900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative genomic hybridization of bronchial carcinomas and their metastases].
    Petersen I; Petersen S; Bockmühl U; Schwendel A; Wolf G; Dietel M
    Verh Dtsch Ges Pathol; 1997; 81():297-305. PubMed ID: 9474883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.
    Nitadori J; Ishii G; Tsuta K; Yokose T; Murata Y; Kodama T; Nagai K; Kato H; Ochiai A
    Am J Clin Pathol; 2006 May; 125(5):682-92. PubMed ID: 16707368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
    Peng WX; Sano T; Oyama T; Kawashima O; Nakajima T
    Lung Cancer; 2005 Feb; 47(2):225-33. PubMed ID: 15639721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
    Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
    Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.
    Ullmann R; Schwendel A; Klemen H; Wolf G; Petersen I; Popper HH
    Hum Pathol; 1998 Oct; 29(10):1145-9. PubMed ID: 9781656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization.
    Ried T; Petersen I; Holtgreve-Grez H; Speicher MR; Schröck E; du Manoir S; Cremer T
    Cancer Res; 1994 Apr; 54(7):1801-6. PubMed ID: 8137295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
    Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
    Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthoracic needle biopsy in the diagnosis of large-cell neuroendocrine carcinoma of the lung.
    Marmor S; Koren R; Halpern M; Herbert M; Rath-Wolfson L
    Diagn Cytopathol; 2005 Oct; 33(4):238-43. PubMed ID: 16138368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas.
    Gugger M; Burckhardt E; Kappeler A; Hirsiger H; Laissue JA; Mazzucchelli L
    J Pathol; 2002 Apr; 196(4):408-15. PubMed ID: 11920736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.